Post-earnings recap
Reported
Thu, May 10, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Amicus Therapeutics reported a loss of $0.35 per share, slightly missing expectations. The stock reacted negatively, dropping 2.68%. Investors may be concerned about the lack of revenue details and guidance, which could indicate uncertainty about the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.35 | N/A | -2.04% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.